Evidence map›Paper›PMID 42363120›Full record

ArticleBMC cancer2026

Prehabilitation in cancer care: an evolving field.

Christopher Gaffney, Jessica Gorzelitz, Jack Reeves, Daniel Steffens

Abstract readEditorial
In one paragraph

Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christopher GaffneyLancaster Medical School, Lancaster University, Lancaster, United Kingdom.
Jessica GorzelitzDepartment of Health, Sport, and Human Physiology, The University of Iowa, Iowa City, United States.
Jack ReevesDiscipline of Physiotherapy, Graduate School of Health, Faculty of Health, University of Technology Sydney, Sydney, Australia.
Daniel SteffensNHMRC Clinical Trials Centre, The University of Sydney, PO Box M157, Missenden Road, Sydney, NSW 2050, Australia. Daniel.Steffens@health.nsw.gov.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer treatment imposes significant physiological and psychological demands on patients whose reserves are already under strain. Prehabilitation, the systematic optimisation of physical, nutritional, and psychological condition prior to cancer treatment, has emerged as a promising strategy to build reserve and accelerate recovery. Yet critical questions remain around patient selection, optimal dose and delivery, and equitable implementation. In this editorial, we outline the current state of evidence, key challenges, and emerging priorities, and invite contributions to BMC Cancer's "Prehabilitation in Cancer Care" Special Collection.

Indexed as

NeoplasmsHumans

Identifiers

PMID42363120
PMCPMC13307680

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.